Heidi, the Australia-based healthcare artificial intelligence (AI) company, announced Thursday the launch of its regional hub in Singapore, following its recent $65 million Series B funding round led by Point72 Private Investments.
The firm said in a statement that the Singapore office will serve as Heidi’s regional headquarters in Southeast Asia, underscoring the company’s long-term commitment to the market.
Heidi plans to invest up to $8 million over the next two to three years, focused on building local teams across sales, implementation, and clinical partnerships, with an estimated hiring target of 10–12 roles during this period.
The company expects to expand the team further as the business grows, supporting customer success, research collaborations, and partnerships with leading healthcare institutions.
Heidi’s entry comes as Singapore faces pressure on its healthcare system, driven by an ageing population and a shortage of clinicians.
By 2030, one in four Singaporeans will be aged 65 or older, with one doctor per 343 residents, a challenge that will only intensify as the population ages.
“For Heidi, Singapore represents more than a market entry, it’s a launchpad for the next phase of healthcare innovation and growth across Southeast Asia,
“Backed by a supportive ecosystem, deep talent pool, and initiatives such as the TRUST platform that enables secure, privacy-conscious data sharing, Singapore is uniquely positioned to accelerate responsible AI adoption in healthcare,” said Dr. Thomas Kelly, Chief Executive Officer and Co-founder of Heidi.
By automating clinical documentation, Heidi’s AI platform helps increase the effective capacity of clinicians, allowing them to dedicate more time to patient care.
The platform, which transcribes doctor-patient conversations into structured clinical notes, has already supported nearly 55,000 consultations in Singapore.
It is noted that primary care, hospitals, and healthcare systems are actively exploring AI capabilities with Heidi, which is already supporting customers such as Osler Group to automate clinical documentation.
Heidi’s Singapore launch builds on its rapid global momentum and recent expansion into Hong Kong.
The company’s AI tools currently process more than 2 million patient consultations weekly, operating in 110 languages across 116 countries.
The latest funding round brings Heidi’s total capital raised to $96.6 million, supported by investors including Point72 Private Investments, Blackbird Ventures, Headline, and LocalGlobe.